PTH-CBD™ Builds Better Bones
The risk of a woman over the age of fifty dying from an osteoporosis-related fracture is greater than the risk of her dying from breast, uterine, and ovarian cancer combined. BiologicsMD™ is developing a new prescription osteoporosis solution based on a unique patent-pending compound that binds to bone and stimulates new bone growth thereby reversing osteoporosis. Pre-clinical animal studies demonstrate that it is three times more effective at increasing bone density than the leading medication with no observed side effects. 2008 revenues for prescription osteoporosis medications exceeded $9 billion globally and $2 billion in the U.S.
CBD binds PTH to bone tissue and provides long-lasting benefits:
• Higher Efficacy
• Fewer Side Effects
• Less Frequent Dosing